A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Morton's Neuroma Clinical Trial

Official title:
An Open-Label, Multiple-Dose Extension Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Status Completed

Clinical Trial Summary

Subjects who have completed study 4975-MN-202 will be eligible to receive open-label treatment with CNTX-4975 200 µg in study 4975-MN-203 if they meet the inclusion/exclusion criteria.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02678793
Study type	Interventional
Source	Centrexion Therapeutics
Contact
Status	Completed
Phase	Phase 2
Start date	December 2015
Completion date	March 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03940963` - Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain	N/A
Recruiting	`NCT00284583` - Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma	N/A
Recruiting	`NCT05695339` - Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain	Phase 1
Completed	`NCT02550756` - Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)	Phase 1
Completed	`NCT01298310` - A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)	Phase 0
Active, not recruiting	`NCT05604144` - Cryoanalgesia for the Treatment of Pain in Subjects With Morton's Neuroma	N/A